Released on: March 6, 2008, 10:23 am

Press Release Author: GTCbio

Industry: Pharmaceuticals

Press Release Summary: Massachusetts Senator Richard T. Moore to give Keynote
Presentation at GTCbio's 4th International Conference on Stem Cell Research &
Therapeutics on April 17-18, 2008 in Boston, MA

Press Release Body: MONROVIA, CA - Senator Richard Moore will speak on April 18,
2008 on recent stem cell legislation and policy initiatives at GTCbio's 4th
International Conference on Stem Cell Research & Therapeutics in Boston, MA.

Senator Richard Moore who is chairman of the Joint Committee on Health Care
Financing is actively involved in current stem cell legislation to reverse
restrictions on stem cell research. The research limits, drafted by Governor Mitt
Romney\'s aides and adopted by the state Public Health Council, generated widespread
criticism from scientists and leading legislators.

Senator Moore will highlight some of the key stem cell issues the state will face in
2008 and in the coming years, including the announcement of Massachusetts' $1
billion stem cell plan. The money would go to support research and enhancing the
work being done at public universities in the state, as well as the creation of a
stem cell bank and a repository of stem cell lines that could be used by researchers
all over the world.

The 4th international conference brings together leading stem cell experts to
discuss new and unreleased information on the latest cutting-edge advancements in
the field including the differentiation of Stem Cells, epigenomics & reprogramming,
imaging, cancer stem cells, applications in drug discovery, regulatory aspects and
funding opportunities. Among the keynote presenters is Dr. Rudolf Jaenisch, the
founding member of the Whitehead Institute and Professor of Biology at MIT speaking
on "Stem Cells, Pluripotency and Nuclear Reprogramming." Other presenting
organizations include Merck, FDA, Genzyme, Geron, Harvard, Applied Biosystems,
Athersys, Cellartis, Pfizer, Novocell, Sanofi-Aventis, Plasticell, Stemagen and
more! Visit www.gtcbio.com or call 626-256-6405 for more information.


Web Site: http://www.gtcbio.com

Contact Details: ABOUT GTCbio

GTCbio organizes conferences specifically for the biomedical and biopharmaceutical
industries. Our goal is to facilitate the exchange of biopharmaceutical and
biomedical intelligence between industry leaders, academic and government
organizations, and the financial community.

GTCbio is a subsidiary of Global Technology Community, LLC, a privately held company
founded in 2002.

Contact: GTCBIO (626) 256-6405, (626) 256-6460 fax, raniah@gtcbio.com